Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors-Reference-Cited by-同舟云学术

Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors

Published:2018-03-30 Issue:4 Volume:143 Page:886-896
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Pan Pan¹^ORCID,Oshima Kiyoko²,Huang Yi-Wen³,Agle Kimberle A.¹,Drobyski William R.¹,Chen Xiao¹,Zhang Jianying⁴,Yearsley Martha M.⁵,Yu Jianhua⁶,Wang Li-Shu⁷

Affiliation:

1. Division of Hematology and Oncology, Department of Medicine; Medical College of Wisconsin; Milwaukee WI

2. Department of Pathology; John Hopkins University; Baltimore MD

3. Department of Obstetrics and Gynecology; Medical College of Wisconsin; Milwaukee WI

4. Center for Biostatistics; The Ohio State University; Columbus OH

5. Department of Pathology; Ohio State University; Columbus OH

6. Division of Hematology, Department of Internal Medicine, College of Medicine; Comprehensive Cancer Center and The James Cancer Hospital, The Ohio State University; Columbus OH

7. Division of Hematology and Oncology, Department of Medicine; Medical College of Wisconsin, RM C4930, 8701 Watertown Plank Rd; Milwaukee WI 53226

Funder

National Institutes of Health

American Cancer Society Research Scholar Grant

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ijc.31366/fullpdf

Reference49 articles.

1. Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2;Lee;Mol Pharmacol,2008